How does Algeria rank globally on Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)?

In 2021, Algeria ranked #124 out of 185 countries reporting Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%).

Algeria: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)

Name: Algeria: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
Creator: World Bank
License: https://datacatalog.worldbank.org/public-licenses#cc-by

In 2021, Algeria's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) was 12.80.

That's up 2.4% from 2020, the highest value since 2019.

The global average for this indicator in 2021 was 16.42 . Algeria ranks #124 globally out of 185 reporting countries. Within Middle East, North Africa, Afghanistan & Pakistan, it ranks #14 of 23.

Source: World Bank Open Data (SH.DYN.NCOM.FE.ZS) • Data as of 2021

Trend (2002–2021)

2020 · COVID-19 pandemic

Highlights

Peak: 16.00; 2002
Trough: 12.50; 2020
1-year change: +2.4%
5-year change: -0.8%; -0.2% / yr
10-year change: -8.6%; -0.9% / yr

Historical Data — Last 10 Years

Year	Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
2021	12.8000
2020	12.5000
2019	12.8000
2018	12.8000
2017	12.8000
2016	12.9000
2015	13.1000
2014	13.2000
2013	13.5000
2012	13.7000

About Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).

Indicator code: SH.DYN.NCOM.FE.ZS • Category: Health & Population

Frequently asked questions

What was Algeria's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) in 2021?: In 2021, Algeria's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) was 12.80, according to World Bank Open Data.
Is Algeria's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) rising or falling?: Algeria's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) rose 2.4% from 2020 to 2021.
How does Algeria rank globally on Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)?: In 2021, Algeria ranked #124 out of 185 countries reporting Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%).
How does Algeria's Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) compare to the world average?: The global average for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) in 2021 was 16.42, so Algeria is below the world average. Within Middle East, North Africa, Afghanistan & Pakistan, it ranks #14 of 23.
What is Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) and how is it measured?: Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).

Download this data: CSV JSON

Source: World Bank Open Data (SH.DYN.NCOM.FE.ZS), CC BY 4.0.